Erythema multiforme due to Rofecoxib [3]

Dermatology

Volumn 204, Issue 4, 2002, Pages 304-305

  Sarkar, Rashmi ^a   Kaur, Charandeep ^a   Kanwar, Amrinder J ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cyclooxygenase 2 inhibition; Erythema multiforme; Rofecoxib

Indexed keywords

ANTIHISTAMINIC AGENT; PREDNISOLONE; ROFECOXIB;

AGED; CASE REPORT; CELL DEATH; CLINICAL EXAMINATION; DERMATITIS; ERYTHEMA MULTIFORME; FEMALE; HUMAN; HUMAN TISSUE; KERATINOCYTE; LETTER; LYMPHOCYTIC INFILTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROVOCATION TEST; RASH; SKIN BIOPSY; STEROID THERAPY;

AGED; CYCLOOXYGENASE INHIBITORS; ERYTHEMA MULTIFORME; FEMALE; HUMANS; LACTONES; SULFONES;

EID: 0036082458     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063367     Document Type: Letter

References (6)

1. COX-2 inhibitors
2. Rofecoxib
3. Allergic skin reaction to celecoxib
4. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme
5. COX-2-selective nonsteroidal anti-inflammatory drugs: Do they really offer any advantage?
6. Erythema multiforme: A critical review of characteristics, diagnostic criteria and causes